Please note that the doses provided are suggested guidelines and may vary for each individual patient. It is crucial to consult with Maureen or one of the other nurses before making any adjustments to your dosage. This ensures that a healthcare professional thoroughly reviews all potential circumstances, ensuring your safety and optimal care.
GLP1 is an FDA-approved medication originally developed to treat type 2 diabetes. Recently, it has gained recognition for its effectiveness in aiding weight loss. GLP1 works by mimicking a hormone called GLP-1 (glucagon-like peptide-1), which targets areas of the brain that regulate appetite and food intake.
Injection Dosage and Titration Schedule
|
WEEKS |
UNITS ON SYRINGE |
MG |
ML |
DIRECTIONS |
|---|---|---|---|---|
|
1 – 4 |
10 |
0.25mg/1mg |
0.10mL |
Inject 10 units on the syringe (0.25mg) subcutaneously once per week |
|
5 – 8 |
20 |
0.50mg/2mg |
0.20mL |
Inject 20 units on the syringe (0.50mg) subcutaneously once per week |
|
9 – 12 |
40 |
1mg/4mg |
0.40mL |
Inject 40 units on the syringe (1mg) subcutaneously once per week |
|
13 – 16 |
60 |
1.5mg/6mg |
0.60mL |
Inject 60 units on the syringe (1.50mg) subcutaneously once per week |
|
17 – 20 |
80 |
2mg/8mg |
0.80mL |
Inject 80 units on the syringe (2mg) subcutaneously once per week |
|
21 – 24 |
100 |
2.5mg/10mg |
1mL |
Inject 100 units on the syringe (2.5mg) subcutaneously once per week |
Pharmacist recommended dosing and titration schedule. Adjust as necessary based on patient response and side effects.
GLP1-GIP is a groundbreaking medication that has shown remarkable effectiveness in aiding weight loss and managing type 2 diabetes. It activates receptors for two key hormones, GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). These hormones play crucial roles in regulating appetite, insulin production, and glucose metabolism.
Injection Dosage and Titration Schedule
|
WEEKS |
UNITS ON SYRINGE |
MG |
ML |
DIRECTIONS |
|---|---|---|---|---|
|
1 – 5 |
20 |
2.5 mg/2 mg |
0.20 mL |
Inject 20 units on the syringe (2.5 mg) subcutaneously every week |
|
6 – 10 |
40 |
5 mg/4 mg |
0.40 mL |
Inject 40 units on the syringe (5 mg) subcutaneously every week |
|
11 – 15 |
60 |
7.5 mg/6 mg |
0.60 mL |
Inject 60 units on the syringe (7.5 mg) subcutaneously every week |
|
16 – 20 |
80 |
10 mg/8 mg |
0.80 mL |
Inject 80 units on the syringe (10 mg) subcutaneously every week |
|
21 – 25 |
100 |
12.5 mg/10 mg |
1 mL |
Inject 100 units on the syringe (12.5 mg) subcutaneously every week |
|
26 – 30 |
120 |
15 mg/12 mg |
1.20 mL |
Inject 120 units on the syringe (15 mg) subcutaneously every week |
Pharmacist recommended dosing and titration schedule. Adjust as necessary based on patient response and side effects.
GLP R is a next-generation medication that activates not just GLP-1 and GIP like GLP1-GIP, but also glucagon receptors—making it a ‘triple agonist.’ Early studies suggest it may produce greater weight loss and metabolic improvements than GLP1-GIP alone.
Injection Dosage and Titration Schedule
|
WEEKS |
UNITS ON SYRINGE** |
MG |
ML |
DIRECTIONS |
|---|---|---|---|---|
|
1 – 4 |
20 |
2mg/2mg |
0.20 mL |
Inject 20 units on the syringe (2 mg) subcutaneously every week |
|
5 – 8 |
40 |
4mg/4mg |
0.40 mL |
Inject 40 units on the syringe (4 mg) subcutaneously every week |
|
9 – 12 |
60 |
6mg/6mg |
0.60 mL |
Inject 60 units on the syringe (6 mg) subcutaneously every week |
|
13 – 16 |
50 |
12mg/5mg |
0.50 mL |
Inject 50 units on the syringe (12 mg) subcutaneously every week |
|
17 – 20 |
65 |
15.6mg/6.5mg |
0.65 mL |
Inject 65 units on the syringe (15.6 mg) subcutaneously every week |
* Pharmacist recommended dosing and titration schedule. Adjust as necessary based on patient response and side effects.
**Units on Syringe and Directions for Weeks 1 – 4, 5 – 8 and 9 – 12 assumes the concentration of your vial is Retatrutide/B6 (Pyridoxine) is (10mg/10mg/mL). Units on Syringe and Directions for Weeks 13 – 16 and 17 – 20 assumes the concentration of your vial is Retatrutide/B6 (Pyridoxine) is (24mg/10mg/mL).
